Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure-Reference-Cited by-同舟云学术

Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell Failure

Published:2023-09 Issue:9 Volume:29 Page:574.e1-574.e10
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Holland Elizabeth M.,Yates Bonnie,Steinberg Seth M.^ORCID,Yuan Constance M.,Wang Hao-Wei,Annesley Colleen,Shalabi Haneen,Stroncek David,Fry Terry J.,Krueger Joerg^ORCID,Jacoby Elad,Hsieh Emily^ORCID,Bhojwani Deepa,Gardner Rebecca A.,Maude Shannon L.,Shah Nirali N.^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference29 articles.

1. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018

2. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

3. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy;Fry;Nat Med,2018

4. Blinatumomab nonresponse and high-disease burden are associated with inferior outcomes after CD19-CAR for B-ALL;Myers;J Clin Oncol,2022

5. Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells;Lamble;Blood Adv,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic transplantation after immunotherapy for relapsed/refractory non-Hodgkin lymphoma: a comparison with a historical cohort;Cytotherapy;2024-05

2. Improving cell reinfusion to enhance the efficacy of chimeric antigen receptor T-cell therapy and alleviate complications;Heliyon;2024-04

3. Broadening the horizon: potential applications of CAR-T cells beyond current indications;Frontiers in Immunology;2023-11-27